[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/main/docs/Benef/index.md) >> Individual ID:PBN__Benef_1019 

# __Increased testing capacity and throughput__

## Description of Benefits pertaining to Beneficiaries

* [Private investors investing in pooled-sample analysis technologies can benefit from increased demand for testing services, potential contracts with healthcare systems, and financial returns from the implementation of these technologies.](https://github.com/mm80843/T3.5/blob/main/docs/BenefReturn/PBN__BenefReturn_1140.md)

## Stakeholders benefitting from this Benefit

* [healthcare systems](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_193.md)
* [public health officials](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_310.md)

## Articles mentionning this Benefit

* [Wastewater surveillance for population-wide Covid-19: The present and future](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_213.md)

## Name of the Benefit

Pooled-sample analysis can greatly increase testing capacity and throughput, allowing for more efficient and widespread testing of populations.

